Verónica Briz-rekin lankidetzan egindako argitalpenak (12)

2009

  1. Raltegravir and etravirine are active against HIV Type 1 group O

    AIDS Research and Human Retroviruses, Vol. 25, Núm. 2, pp. 225-227

2008

  1. Impact of antiretroviral therapy on chemokine (C-C motif) receptor 5 expression in HIV patients followed for over 2 years

    AIDS, Vol. 22, Núm. 11, pp. 1371-1374

  2. Impact of antiretroviral therapy on viral tropism in HIV-infected patients followed longitudinally for over 5 years

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 2, pp. 405-410

2007

  1. Correlation between a phenotypic assay and three bioinformatic tools for determining HIV co-receptor use

    AIDS, Vol. 21, Núm. 11, pp. 1487-1490

  2. Prevalence of X4 tropic HIV-1 variants in patients with differences in disease stage and exposure to antiretroviral therapy

    Journal of Medical Virology, Vol. 79, Núm. 8, pp. 1040-1046

  3. Prevalence of darunavir resistance mutations in HIV-1-infected patients failing other protease inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 60, Núm. 4, pp. 885-888

  4. Short communication: Dynamics of drug-resistant HIV-1 in plasma and peripheral blood cells in patients during and after enfuvirtide therapy

    AIDS Research and Human Retroviruses, Vol. 23, Núm. 9, pp. 1078-1082

2006

  1. Entrada del virus de la inmunodeficiencia humana en las células: Mecanismos y posibilidades terapéuticas

    Medicina Clinica, Vol. 126, Núm. 9, pp. 341-348

  2. HIV entry inhibitors: Mechanisms of action and resistance pathways

    Journal of Antimicrobial Chemotherapy, Vol. 57, Núm. 4, pp. 619-627

  3. HIV tropism: Diagnostic tools and implications for disease progression and treatment with entry inhibitors

    AIDS, Vol. 20, Núm. 10, pp. 1359-1367

  4. Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitors

    AIDS, Vol. 20, Núm. 11, pp. 1558-1560

2005

  1. Enfuvirtide, the first fusion inhibitor to treat HIV infection

    AIDS Reviews, Vol. 7, Núm. 3, pp. 139-147